Article
Optical genome mapping identifies a novel <i>PSIP1::TBL1X</i> fusion in metastatic pancreatic neuroendocrine tumors
2025-12-19
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background and aims</h4> Effective treatment of metastatic neuroendocrine tumors (NETs) is limited by a lack of targeted therapies and clinically useful predictive biomarkers. We applied complementary genomic profiling technologies to identify genomic alterations that could lead to actionable drug targets and biomarkers. <h4>Methods</h4> Optical genome mapping (OGM) and whole exome sequenc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 011c85e8-f8f9-50a5-9b95-dbee2ed50f19
- DOI
- 10.64898/2025.12.17.694687
